Virtus LifeSci Biotech Products ETF
17 hedge funds and large institutions have $11.9M invested in Virtus LifeSci Biotech Products ETF in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
75% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 8
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.2M | |
| 2 | +$217K | |
| 3 | +$49.8K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$4K |
Top Sellers
| 1 | -$1.16M | |
| 2 | -$76.9K | |
| 3 | -$52.2K | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$34.8K |
| 5 |
PMFA
Plante Moran Financial Advisors
Southfield,
Michigan
|
-$30K |